This inventor holds 2 USPTO granted patents. Top assignee: Beckman Research Institute, City of Hope. Active years: 2011-2015.
Company Filing History:
Years Active: 2011-2015
Title: Britta Hoehn: Innovator in RNA Technology
Introduction
Britta Hoehn is a prominent inventor based in Hagen, Germany. She has made significant contributions to the field of RNA technology, particularly in the development of novel short interfering RNA (siRNA) molecules. With a total of 2 patents, her work is paving the way for advancements in genetic research and therapeutic applications.
Latest Patents
Britta's latest patents focus on multi-targeting short interfering RNAs. The present invention relates to novel siRNA molecules that are designed to target two or more sequences. In one embodiment, these multi-targeting siRNA molecules incorporate features of both siRNA and micro-RNA (miRNA) molecules. In another embodiment, each strand of the multi-targeting siRNA is directed to separate targets, enhancing the potential for therapeutic efficacy.
Career Highlights
Britta Hoehn is currently associated with City of Hope, where she continues to innovate in the field of RNA technology. Her work has garnered attention for its potential applications in treating various diseases through targeted genetic interventions.
Collaborations
Some of her notable coworkers include Lars Aagaard and Ola Snove, who contribute to the collaborative environment that fosters innovation at City of Hope.
Conclusion
Britta Hoehn's contributions to RNA technology exemplify the impact of innovative thinking in the field of genetics. Her work on multi-targeting siRNA molecules is a testament to her dedication to advancing scientific knowledge and therapeutic possibilities.